Stephen L. Eck - 07 Feb 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Reporting relationship: Chief Medical Officer
Issuer ticker: MGNX
Reported as of: 07 Feb 2025
Net transaction value: -$8,611
SEC form: 4
Accepted by SEC: 11 Feb 2025, 20:34:43 UTC
Prior SEC filing: 20 Feb 2024
Next SEC filing: 19 Feb 2025
Source filing: View source filing
Reporting owner signature: Beth A. Smith, Attorney-in-fact

Key filing fact

Stephen L. Eck filed Form 4 for MACROGENICS INC (MGNX) on 11 Feb 2025.

Key facts

This page summarizes Stephen L. Eck's Form 4 filing for MACROGENICS INC (MGNX).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 11 Feb 2025, 20:34.

Change

Previous filing in this sequence was filed on 20 Feb 2024.
Current net transaction value: -$8,611.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MGNX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +11,168
Change %: +114%
Price: $0.000000
Shares after: 20,966
Date: 08 Feb 2025
Ownership: Direct
Footnotes: F1

MGNX transaction

Common Stock

Tax liability

Transaction value: $8,611
Shares: -3,312
Change %: -16%
Price: $2.60
Shares after: 17,654
Date: 08 Feb 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MGNX transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +113,000
Change %
Price: $0.000000
Shares after: 113,000
Date: 07 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 113,000
Exercise price: $2.60
Footnotes: F2

MGNX transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +19,000
Change %
Price: $0.000000
Shares after: 19,000
Date: 07 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,000
Exercise price
Footnotes: F1, F3

MGNX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -11,168
Change %: -33%
Price: $0.000000
Shares after: 22,332
Date: 08 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,168
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

Footnote F2

12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

Footnote F3

Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.